In our study, after a series of sifting and analysis, three immune‐ and inflammation‐associated genes (CTSD, CEBPD and CYP27A1) were identified for predicting the CAD progression in patients with IBD. This evidence concerns the gene CEBPD and inflammatory bowel disease.